✨ Government Appointments and Medicine Approvals




566 NEW ZEALAND GAZETTE, No. 25 4 MARCH 2010

Appointment to the Tertiary Education Commission Board

Pursuant to section 159D of the Education Act 1989 and section 28 of the Crown Entities Act 2004, I appoint to the Tertiary Education Commission Board

Kaye Turner

as interim chair for a three-month term which commenced on 26 February 2010 and expires on 25 May 2010.

Dated at Wellington this 26th day of February 2010.

HON STEVEN JOYCE, Minister for Tertiary Education.

go1597

Health

Medicines Act 1981

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 2mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Kyowa Hakko Kogyo Co Limited, Tokyo, Japan
Note: This consent is valid for 2 years from the date of publication of this notice.

Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 10mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Kyowa Hakko Kogyo Co Limited, Tokyo, Japan
Note: This consent is valid for 2 years from the date of publication of this notice.

Product: Mitomycin-C-Kyowa
Active Ingredient: Mitomycin 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Kyowa Hakko Kogyo Co Limited, Tokyo, Japan
Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 24th day of February 2010.

ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1667

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Topamax
Active Ingredient: Topiramate 25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Cilag AG, Schaffhausen, Switzerland

Product: Topamax
Active Ingredient: Topiramate 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Cilag AG, Schaffhausen, Switzerland



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 25





✨ LLM interpretation of page content

πŸŽ“ Appointment to the Tertiary Education Commission Board

πŸŽ“ Education, Culture & Science
26 February 2010
Tertiary Education Commission, Board Appointment, Interim Chair
  • Kaye Turner, Appointed interim chair of Tertiary Education Commission Board

  • HON STEVEN JOYCE, Minister for Tertiary Education

πŸ₯ Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
24 February 2010
Medicines Act, Provisional Consent, Mitomycin-C-Kyowa, Bristol-Myers Squibb, Kyowa Hakko Kogyo Co Limited
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
24 February 2010
Medicines Act, Consent, Topamax, Topiramate, Janssen-Cilag, Cilag AG
  • ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health